Carbetocin Aguettant

Carbetocin Aguettant is a synthetic oxytocin analog used for postpartum hemorrhage prevention. This medication is administered intramuscularly or intravenously to support uterine contraction.

Carbetocin Aguettant is primarily used to prevent postpartum hemorrhage by promoting uterine contraction. It is administered intramuscularly or intravenously to help manage bleeding after childbirth. This medication is often used in clinical settings to ensure the uterus contracts effectively, reducing the risk of excessive bleeding.

Carbetocin Aguettant works by mimicking the effects of natural oxytocin, which helps the uterus contract. This can lead to reduced bleeding and improved uterine tone. Common effects may include increased uterine contractions and a decrease in postpartum hemorrhage.

Carbetocin Aguettant should be used with caution in individuals with a history of hypersensitivity to oxytocin or similar compounds. It is important to follow medical guidance when administering this medication to ensure safety and effectiveness. Always consult a healthcare provider before use.

Carbetocin Aguettant may interact with other medications that affect uterine contractions or blood pressure. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain CYP inhibitors may also affect the efficacy of this medication.